• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院 COVID-19 患者中的急性脑血管事件。

Acute Cerebrovascular Events in Hospitalized COVID-19 Patients.

机构信息

Department of Neurology, University of Pennsylvania, Philadelphia.

出版信息

Stroke. 2020 Sep;51(9):e219-e222. doi: 10.1161/STROKEAHA.120.030995. Epub 2020 Jul 20.

DOI:10.1161/STROKEAHA.120.030995
PMID:32684145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7386677/
Abstract

BACKGROUND AND PURPOSE

Initial reports suggest a significant risk of thrombotic events, including stroke, in patients hospitalized with coronavirus disease 2019 (COVID-19). However, there is little systematic data on stroke incidence and mechanisms, particularly in racially diverse populations in the United States.

METHODS

We performed a retrospective, observational study of stroke incidence and mechanisms in all patients with COVID-19 hospitalized from March 15 to May 3, 2020, at 3 Philadelphia hospitals.

RESULTS

We identified 844 hospitalized patients with COVID-19 (mean age 59 years, 52% female, 68% Black); 20 (2.4%) had confirmed ischemic stroke; and 8 (0.9%) had intracranial hemorrhage. Of the ischemic stroke patients, mean age was 64 years, with only one patient (5%) under age 50, and 80% were Black. Conventional vascular risk factors were common, with 95% of patients having a history of hypertension and 60% a history of diabetes mellitus. Median time from onset of COVID symptoms to stroke diagnosis was 21 days. Stroke mechanism was cardioembolism in 40%, small vessel disease in 5%, other determined mechanism in 20%, and cryptogenic in 35%. Of the 11 patients with complete vascular imaging, 3 (27%) had large vessel occlusion. Newly positive antiphospholipid antibodies were present in >75% of tested patients. Of the patients with intracranial hemorrhage, 5/8 (63%) were lobar intraparenchymal hemorrhages, and 3/8 (38%) were subarachnoid hemorrhage; 4/8 (50%) were on extracorporeal membrane oxygenation.

CONCLUSIONS

We found a low risk of acute cerebrovascular events in patients hospitalized with COVID-19. Most patients with ischemic stroke had conventional vascular risk factors, and traditional stroke mechanisms were common.

摘要

背景与目的

最初的报告表明,患有 2019 年冠状病毒病(COVID-19)的住院患者发生血栓栓塞事件(包括中风)的风险显著增加。然而,在美国,关于中风发病率和发病机制的系统数据很少,尤其是在种族多样化的人群中。

方法

我们对 2020 年 3 月 15 日至 5 月 3 日期间,3 家费城医院收治的所有 COVID-19 住院患者的中风发病率和发病机制进行了回顾性、观察性研究。

结果

我们共确定了 844 例 COVID-19 住院患者(平均年龄 59 岁,52%为女性,68%为黑人);其中 20 例(2.4%)确诊为缺血性中风,8 例(0.9%)发生颅内出血。缺血性中风患者的平均年龄为 64 岁,仅有 1 例(5%)年龄小于 50 岁,80%为黑人。常见的传统血管危险因素,95%的患者有高血压病史,60%有糖尿病病史。从 COVID 症状发作到中风诊断的中位时间为 21 天。中风机制为心源性栓塞占 40%,小血管疾病占 5%,其他确定机制占 20%,隐源性占 35%。在 11 例完成血管影像学检查的患者中,3 例(27%)存在大血管闭塞。超过 75%的检测患者新出现抗磷脂抗体阳性。8 例颅内出血患者中,5/8(63%)为脑叶实质内出血,3/8(38%)为蛛网膜下腔出血;4/8(50%)在体外膜肺氧合。

结论

我们发现 COVID-19 住院患者发生急性脑血管事件的风险较低。大多数缺血性中风患者有传统的血管危险因素,常见的传统中风机制。

相似文献

1
Acute Cerebrovascular Events in Hospitalized COVID-19 Patients.住院 COVID-19 患者中的急性脑血管事件。
Stroke. 2020 Sep;51(9):e219-e222. doi: 10.1161/STROKEAHA.120.030995. Epub 2020 Jul 20.
2
Emergent Large Vessel Occlusion Stroke During New York City's COVID-19 Outbreak: Clinical Characteristics and Paraclinical Findings.新冠疫情期间纽约市出现的紧急大血管闭塞性卒中:临床特征和辅助检查结果。
Stroke. 2020 Sep;51(9):2656-2663. doi: 10.1161/STROKEAHA.120.030397. Epub 2020 Jul 31.
3
Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019.新型冠状病毒病的缺血性和出血性脑血管并发症。
Int J Stroke. 2020 Oct;15(7):733-742. doi: 10.1177/1747493020937189. Epub 2020 Jun 26.
4
Cerebrovascular Complications of COVID-19.新型冠状病毒病的脑血管并发症。
Stroke. 2020 Sep;51(9):e227-e231. doi: 10.1161/STROKEAHA.120.031265. Epub 2020 Aug 6.
5
COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome.与 COVID-19 相关的神经影像学表现:血栓栓塞并发症的信号和患者预后不良的强预后标志物。
J Neurol Sci. 2020 Jul 15;414:116923. doi: 10.1016/j.jns.2020.116923. Epub 2020 May 19.
6
SARS-CoV-2 and Stroke in a New York Healthcare System.SARS-CoV-2 与纽约医疗体系中的中风。
Stroke. 2020 Jul;51(7):2002-2011. doi: 10.1161/STROKEAHA.120.030335. Epub 2020 May 20.
7
Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry.新型冠状病毒肺炎住院患者的脑血管事件及转归:SVIN新型冠状病毒肺炎多国注册研究
Int J Stroke. 2021 Jun;16(4):437-447. doi: 10.1177/1747493020959216. Epub 2020 Sep 30.
8
Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex.具有 SARS-CoV-2 的多样化卒中患者的特征及按性别划分的预后。
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105314. doi: 10.1016/j.jstrokecerebrovasdis.2020.105314. Epub 2020 Sep 11.
9
COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature.COVID-19 与缺血性脑卒中:文献的系统评价和汇总分析。
J Thromb Thrombolysis. 2020 Oct;50(3):587-595. doi: 10.1007/s11239-020-02228-y.
10
Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients.COVID-19 患者的系统性动脉血栓栓塞事件的发生率和后果。
J Thromb Thrombolysis. 2020 Oct;50(3):543-547. doi: 10.1007/s11239-020-02176-7.

引用本文的文献

1
Antiphospholipid Antibodies and COVID-19: A Systematic Review of Clinical Implications.抗磷脂抗体与新型冠状病毒肺炎:临床意义的系统评价
Immun Inflamm Dis. 2025 Feb;13(2):e70134. doi: 10.1002/iid3.70134.
2
Radiologic and Clinical Characteristics of Stroke Patients with Covid-19: A Case-Control Study.新冠肺炎中风患者的放射学和临床特征:一项病例对照研究。
Noro Psikiyatr Ars. 2024 Nov 30;61(4):345-350. doi: 10.29399/npa.28642. eCollection 2024.
3
Incidence and Features of Acute Ischemic Stroke in Patients Hospitalized with COVID-19: A Multi-center Study in Turkey.COVID-19住院患者急性缺血性卒中的发病率及特征:土耳其的一项多中心研究
Noro Psikiyatr Ars. 2024 Jul 24;67(3):241-247. doi: 10.29399/npa.28493. eCollection 2024.
4
Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications.新型冠状病毒肺炎相关神经系统并发症:病理生理学基础与治疗意义。
Viruses. 2024 Jul 24;16(8):1183. doi: 10.3390/v16081183.
5
A Comprehensive Review on Navigating the Neurological Landscape of COVID-19: Insights Into Etiopathogenesis and Clinical Management.关于探索新冠病毒神经领域的全面综述:病因发病机制及临床管理见解
Cureus. 2024 May 11;16(5):e60079. doi: 10.7759/cureus.60079. eCollection 2024 May.
6
Case report: unprecedented case of infantile cerebral infarction following COVID-19 and favorable outcome.病例报告:COVID-19 后婴儿脑梗死的空前病例及良好结局。
Front Immunol. 2024 Mar 25;15:1357307. doi: 10.3389/fimmu.2024.1357307. eCollection 2024.
7
Clinical Features and Treatment of Patients Infected With SARS-CoV-2 Omicron Variant While Hospitalized Due to Stroke: A Single Center Study in Japan.因中风住院的感染新型冠状病毒奥密克戎变异株患者的临床特征与治疗:日本一项单中心研究
Cureus. 2024 Feb 23;16(2):e54760. doi: 10.7759/cureus.54760. eCollection 2024 Feb.
8
COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage.新型冠状病毒肺炎与脑:认识神经系统损伤的发病机制和后果。
Mol Biol Rep. 2024 Feb 22;51(1):318. doi: 10.1007/s11033-024-09279-x.
9
Acute cerebrovascular events and inflammatory markers associated with COVID-19: An observational study.急性脑血管事件与 COVID-19 相关的炎症标志物:一项观察性研究。
J Med Life. 2023 Oct;16(10):1482-1487. doi: 10.25122/jml-2023-0283.
10
Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke.2019冠状病毒病相关卒中的流行病学、发病机制及管理
Front Med. 2023 Dec;17(6):1047-1067. doi: 10.1007/s11684-023-1041-7. Epub 2024 Jan 2.

本文引用的文献

1
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
2
SARS-CoV-2 and Stroke in a New York Healthcare System.SARS-CoV-2 与纽约医疗体系中的中风。
Stroke. 2020 Jul;51(7):2002-2011. doi: 10.1161/STROKEAHA.120.030335. Epub 2020 May 20.
3
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高:更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
4
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.意大利米兰一家学术医院收治的 COVID-19 患者的静脉和动脉血栓栓塞并发症。
Thromb Res. 2020 Jul;191:9-14. doi: 10.1016/j.thromres.2020.04.024. Epub 2020 Apr 23.
5
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
6
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
7
Infections and the antiphospholipid syndrome.感染与抗磷脂综合征
Clin Rev Allergy Immunol. 2009 Jun;36(2-3):104-8. doi: 10.1007/s12016-008-8103-0.
8
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.急性缺血性卒中亚型分类。多中心临床试验中使用的定义。TOAST。急性卒中治疗中Org 10172试验。
Stroke. 1993 Jan;24(1):35-41. doi: 10.1161/01.str.24.1.35.